Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
VALEANT PHARMACEUTICALS INTERNATIONAL (NY: VRX)
122.05 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 6:40 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 121.95 (100)
Ask (Size) 122.12 (100)
Prev. Close 122.05
Today's Range 122.05 - 122.05
52wk Range 71.97 - 153.10
Shares Outstanding 333,413,077
Dividend Yield N/A
Performance
YTD
+4.33%
+4.33%
1 Month
-13.31%
-13.31%
3 Month
-11.51%
-11.51%
6 Month
+7.99%
+7.99%
1 Year
+67.63%
+67.63%
Top News
More News
30-Year Ultra Long Gilt Futures Updates, Partnerships, Notes Offer Pricings, and Drug Approvals - Analyst Notes on IntercontinentalExchange, Western Union, Essex Property , Valeant and Pharmacyclics
April 15, 2014
Editor Note: For more information about this release, please scroll to bottom. Read More
from PR Newswire
Favourable Rulings, Topline Results, Earnings Schedules, Approvals, and New Advisory Boards - Analyst Notes on Lilly, UnitedHealth Group, Valeant, Forest Laboratories, and Zoetis
April 11, 2014
Editor Note: For more information about this release, please scroll to bottom. Read More
from PR Newswire
More News
Read More
Health Care Stocks Technical Coverage -- Research on Valeant Pharma Intl., Alkermes, Delcath Systems, and Acura Pharma
April 09, 2014
from PR Newswire
Drug Recommendations, Legal Updates, Awards, Stock Price Movements, and Upcoming Results and Conference Call Schedules - Analyst Notes on MannKind, Mylan, WellPoint, Valeant, and Forest Laboratories
April 07, 2014
from PR Newswire
Icon Bioscience Announces David S. Tierney, MD Joined the Company as President & Chief Executive Officer
April 07, 2014
from Business Wire News Releases
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%
March 25, 2014
from PR Newswire
Valeant Pharmaceuticals International Down 14.8% Since SmarTrend Downtrend Call (VRX)
April 15, 2014
from Comtex SmarTrend® News Briefs
Meet the poster child for momentum stock selloff
April 10, 2014
category tvcodes/tvnn , Investing/Market Outlook , Valeant Pharmaceuticals International , and 11 more.
from CNBC.com News
Valeant Pharmaceuticals International Inc is Now Oversold (VRX.CA)
April 07, 2014
category Dividends
from Dividend Channel
Valeant Pharmaceuticals International Crosses Below its 10-day MA (VRX)
April 10, 2014
from Comtex SmarTrend® News Briefs
Valeant Pharmaceuticals International - Market Digest
April 07, 2014
from AVAFIN
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here